Silverio Ros
Impact in
-
- Venous Thromboembolism Diagnosis and Management
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
-
- Venous Thromboembolism Diagnosis and Management 4
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- Bone health and treatments 1
- Co-authors
- José Luis Alonso-Romero (5 shared papers)Diana Navas-Carrillo (1 shared paper)Esteban Orenes‐Piñero (2 shared papers)Álvaro Pinto (1 shared paper)Álvaro Montesa (1 shared paper)Marta Guix (1 shared paper)María José Méndez-Vidal (1 shared paper)Isabel Chirivella (1 shared paper)
In The Last Decade
Silverio Ros
12 papers receiving 240 citations
Silverio Ros's Hit Papers
Peers
Comparison fields: 5 of 37
- Internal Medicine 22
- Oncology 74
- Pulmonary and Respiratory Medicine 96
- Cancer Research 13
- Dermatology 7
Countries citing papers authored by Silverio Ros
This map shows the geographic impact of Silverio Ros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silverio Ros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silverio Ros more than expected).
Fields of papers citing papers by Silverio Ros
This network shows the impact of papers produced by Silverio Ros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silverio Ros. The network helps show where Silverio Ros may publish in the future.
Co-authors
The 25 scholars most cited alongside Silverio Ros, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study Hit paper breakdown → | 2024 | 92 |
| 2 | 2020 | 25 | |
| 3 | 2018 | 24 | |
| 4 | 2018 | 21 | |
| 5 | 2020 | 20 | |
| 6 | 2021 | 18 | |
| 7 | 2021 | 11 | |
| 8 | 2024 | 11 | |
| 9 | 2016 | 10 | |
| 10 | 2009 | 5 | |
| 11 | 2023 | 4 | |
| 12 | 2024 | 3 | |
| 13 | 2024 | 0 | |
| 14 | 2025 | 0 | |
| 15 | 2025 | 0 | |
| 16 | 2025 | 0 | |
| 17 | 2026 | 0 |
About Silverio Ros
Silverio Ros is a scholar working on Internal Medicine, Oncology, Pulmonary and Respiratory Medicine, Dermatology and Genetics, having authored 17 papers that have together received 244 indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (2 papers), Testicular diseases and treatments (2 papers), Erythropoietin and Anemia Treatment (1 paper), Lung Cancer Diagnosis and Treatment (1 paper), Bone health and osteoporosis research (1 paper) and Bone health and treatments (1 paper). The work is most often cited by research in Internal Medicine (22 citations), Oncology (74 citations), Pulmonary and Respiratory Medicine (96 citations), Cancer Research (13 citations) and Dermatology (7 citations). Silverio Ros has collaborated with scholars based in Spain, Mexico and Portugal. Frequent co-authors include José Luis Alonso-Romero, Diana Navas-Carrillo, Esteban Orenes‐Piñero, Álvaro Pinto, Álvaro Montesa, Marta Guix, María José Méndez-Vidal, Isabel Chirivella, Enrique Gallardo and Elena Brozos-Vázquez. Their work appears in journals such as Clinical & Translational Oncology, Cancer Management and Research, BMC Pharmacology and Toxicology, International Journal of Clinical Pharmacy and Pigment Cell & Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.